These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 9846889)
41. Advanced glycation end products and diabetic retinopathy. Sharma Y; Saxena S; Mishra A; Saxena A; Natu SM J Ocul Biol Dis Infor; 2012 Dec; 5(3-4):63-9. PubMed ID: 24596941 [TBL] [Abstract][Full Text] [Related]
42. Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Bodiga VL; Eda SR; Bodiga S Heart Fail Rev; 2014 Jan; 19(1):49-63. PubMed ID: 23404649 [TBL] [Abstract][Full Text] [Related]
43. Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects. Hu H; Han CM; Hu XL; Ye WL; Huang WJ; Smit AJ J Zhejiang Univ Sci B; 2012 May; 13(5):372-7. PubMed ID: 22556175 [TBL] [Abstract][Full Text] [Related]
44. Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosis. Hettema ME; Bootsma H; Graaff R; de Vries R; Kallenberg CG; Smit AJ Int J Rheumatol; 2011; 2011():417813. PubMed ID: 21977038 [TBL] [Abstract][Full Text] [Related]
45. Cells and tissue interactions with glycated collagen and their relevance to delayed diabetic wound healing. Liao H; Zakhaleva J; Chen W Biomaterials; 2009 Mar; 30(9):1689-96. PubMed ID: 19157537 [TBL] [Abstract][Full Text] [Related]
46. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Meerwaldt R; Links T; Zeebregts C; Tio R; Hillebrands JL; Smit A Cardiovasc Diabetol; 2008 Oct; 7():29. PubMed ID: 18840258 [TBL] [Abstract][Full Text] [Related]
47. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Meerwaldt R; Links TP; Graaff R; Hoogenberg K; Lefrandt JD; Baynes JW; Gans RO; Smit AJ Diabetologia; 2005 Aug; 48(8):1637-44. PubMed ID: 16021416 [TBL] [Abstract][Full Text] [Related]
49. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products. Mera K; Nagai M; Brock JW; Fujiwara Y; Murata T; Maruyama T; Baynes JW; Otagiri M; Nagai R J Immunol Methods; 2008 May; 334(1-2):82-90. PubMed ID: 18353354 [TBL] [Abstract][Full Text] [Related]
50. Advanced glycoxidation end products in commonly consumed foods. Goldberg T; Cai W; Peppa M; Dardaine V; Baliga BS; Uribarri J; Vlassara H J Am Diet Assoc; 2004 Aug; 104(8):1287-91. PubMed ID: 15281050 [TBL] [Abstract][Full Text] [Related]
51. Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts". Richter T; Münch G; Lüth HJ; Arendt T; Kientsch-Engel R; Stahl P; Fengler D; Kuhla B Neurobiol Aging; 2005 Apr; 26(4):465-74. PubMed ID: 15653175 [TBL] [Abstract][Full Text] [Related]
52. Novel application of surface plasmon resonance biosensor chips for measurement of advanced glycation end products in serum of Zucker diabetic fatty rats. Kim YS; Yi SY; Kim J; Kim M; Kim CS; Chung BH; Kim JS Biosens Bioelectron; 2009 Sep; 25(1):248-52. PubMed ID: 19589671 [TBL] [Abstract][Full Text] [Related]
53. Factors in human serum interfere with the measurement of advanced glycation endproducts. Dorrian CA; Cathcart S; Clausen J; Shapiro D; Dominiczak MH Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1069-79. PubMed ID: 9846889 [TBL] [Abstract][Full Text] [Related]
54. Recent advances in detection of AGEs: Immunochemical, bioanalytical and biochemical approaches. Ashraf JM; Ahmad S; Choi I; Ahmad N; Farhan M; Tatyana G; Shahab U IUBMB Life; 2015 Dec; 67(12):897-913. PubMed ID: 26597014 [TBL] [Abstract][Full Text] [Related]